A Statistical Issue About a Phase III Multi-regional Trial for the Survival Data under Accelerated Failure Time Model with Unrecognized Heterogeneity

DOI10.1080/03610926.2013.786787zbMath1462.62671OpenAlexW2034750375MaRDI QIDQ3462389

Feng-shou Ko

Publication date: 5 January 2016

Published in: Communications in Statistics - Theory and Methods (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1080/03610926.2013.786787

zbMATH Keywords

heterogeneitymulti-regional studyregional sample size

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Related Items (3)

Comparisons of a multi-regional trial for four or five regions by fixed effect model and random effect model about allocating sample size rationally into individual regions for a multi-regional trial ⋮ The issue about sample size for survival analysis considering the interaction of unrecognized heterogeneity and treatment ⋮ An issue about the efficacy for the time-to-event outcome based on accelerated failure time model with interaction of unrecognized heterogeneity and main effect

Cites Work

• The Use of Frailty Hazard Models for Unrecognized Heterogeneity That Interacts with Treatment: Considerations of Efficiency and Power
• Properties of Proportional-Hazards Score Tests under Misspecified Regression Models
• Misspecified proportional hazard models

This page was built for publication: A Statistical Issue About a Phase III Multi-regional Trial for the Survival Data under Accelerated Failure Time Model with Unrecognized Heterogeneity